Skip to main content

Sub Orbital Reusable Vehicle Market Competitive Research and Global Outlook 2021-2031


In the past, before the emergence of private space companies, the space industry was dominated by national space agencies across the globe. Currently, with the advent of new space players, the dynamics in the space industry have transformed. Moreover, it is observed that space agencies and private space companies are working with each other to further their objectives with respect to the space industry. The advantages of space systems for mobile satellite communications, broadcasting, high-speed data transfer, and commercial navigation are being recognized today by commercial businesses. Furthermore, there are numerous potential opportunities offered by emerging space activities such as in-space manufacturing, asteroid mining, and space-based solar power. These space activities are gathering significant interest from the private sector.

Space transportation includes sub-orbital flights or transportation, orbital transportation, and beyond orbital transportation, which includes planetary missions. Currently, commercial space transportation includes launch services and cargo delivery to the International Space Station (ISS). Additionally, two companies, namely Blue Origin and Virgin Galactic, have announced their ticket prices for commercial space transportation services. These commercial space transportation services include one to the Moon and one to higher orbits from the International Space Station (ISS) or launch vehicle. Apart from this, commercial rides will be available for adventure travelers and astronauts on suborbital flights and to the ISS. According to NASA’s Integrated Landing System Broad Agency Announcement (BAA), transportation from Gateway to the Moon will be a commercial service by 2024.

Sub-orbital transportation not only includes using spacecraft for microgravity experiments, satellite deployments, or cargo delivery but also encompasses space tourism. Space tourism has been one of the focused areas in the space industry, particularly for commercial space entities. The main objective of space tourism companies is to fly paying customers to space. From 2001 to 2009, private individuals were successfully sent into space aboard a Russian Soyuz spacecraft. Space Adventures, a space tourism company, organized eight space flight tours to the ISS for seven private individuals with the help of Russia’s Space Agency.

Remote sensing/Earth observation is the technique for acquiring information from a distance using sensors onboard satellites; images of large areas on the Earth’s surface are taken for required data. Earlier, the data collection process through remote sensing was considered a costly affair as it required a pilot and an aircraft that needed to be maneuvered on difficult terrains, posing a substantial risk. The use of SRVs for remote sensing presents an opportunity to carry-out Safe and responsive intelligence, surveillance, and reconnaissance.

Space tourism has gathered significant interest from the space sector as well as individuals who want to travel to space. Several companies such as Virgin Galactic, Blue Origin, Space Adventures, PD AeroSpace, LTD, Space Perspective, and Zero Gravity Corporation are focusing on developing platforms that will enable space tourism. The current challenge is to make space trips cheaper and thus more accessible to the public.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...